Biochemical Reagent
-
BA9214 SLU-PP-332Summary: An ERRα, ERRβ, and ERRγ agonist -
BA9215 ERD-308Summary: ERD-308 is a potent, E3 ligand-based PROTAC with potential for use in ER-positive breast cancer research. - BA9216 EquilinSummary: Equilin (7-Dehydroestrone) is an important member of a large class of estrogenic substances chemically related to estradiol.
- BA9217 RaloxifeneSummary: Raloxifene (Keoxifene) is a benzothiophene selective estrogen receptor modulator (SERM) with estrogenic agonistic effects on bone and lipids and estrogenic antagonistic effects on the breast and uterus.
- BA9218 DS45500853Summary: DS45500853 is an estrogen-related receptor alpha agonist.
- BA9219 DK3Summary: A potent and selective estrogen-related receptor alpha agonist.
- BA9220 LSZ-102Summary: A potent, orally bioavailable, selective estrogen receptor degrader.
- BA9221 H3B-5942Summary: H3B-5942 is a selective, irreversible, orally available covalent antagonist capable of targeting Cys530 and inactivating wild-type and mutant with values of 1 nM and 0.41 nM, respectively.
- BA9222 ImlunestrantSummary: Immunestrant (LY-3484356) is an orally effective and selective estrogen receptor degrader (SERD) with pure antagonistic properties.
- BA9223 H3B-6545Summary: H3B-6545 is a potent, orally active, selective estrogen receptor covalent antagonist.